C-EHRN hosted an online launch and discussion of the 2022 Monitoring Report on the 23rd February. During this webinar, key findings and results in Essential Harm Reduction Services, Hepatitis C and Drug Use, and New Drug Trends in Europe were discussed. Implications and opportunities for civil society advocacy, service provision and policy development were also addressed.
Speakers;
Katrin Schiffer (CEHRN), Rafaela Rigoni (CEHRN), Iga Jeziorska (CEHRN), Daan van der Gouwe (Trimbos-Instituut), Tuukka Tammi (THL), Perrine Roux (Inserm), Mat Southwell (EuroNPUD) and Alexei Lahov (Humanitarian Action).
Watch the full recording here.
C-EHRN is proud and grateful to present its 2023 Network Report, providing a summarised version of the activities undertaken last year. In this document, we are looking back at a year full of tasks, challenges and opportunities.
Multiple authors 
“Viral hepatitis B and C are two deadly viruses whose burden is greater than HIV/AIDS and Tuberculosis combined. According to the WHO Global Strategy from 2016, which builds on the UN Sustainable Development Goals (SDGs), viral hepatitis B and C can be eliminated by 2030. An effective vaccine exists for hepatitis B, and affordable, easy-to-administer, […]
Multiple authors
